Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ

Minghua Wu(Northwestern University), John Varga(Northwestern University)
American Journal Of Pathology
January 16, 2009
Cited by 227


Related Papers